Preview

Medical and Biological Problems of Life Activity

Advanced search

Major indicators of insulin resistance in risk assessement of diabetes mellitus development

Abstract

To study clinical and laboratory indicators for algorithm design of early detection of insulin resistance and diabetes mellitus type 2 (DM 2). The study was conducted within 140 people of working age with body mass excess or obesity. The risk of the development of insulin resistance increases with the preperitoneal fat thickness (b=1,46) (ехр (b)=4,29 (1,54÷1,90), р=0,005): when the amount of preperitoneal fat more than 1,50 cm a relative risk (RR) of insulin resistance (IR) formation was 5,60 (2,48÷37,11). The risk of the development of IR with the triglycerides level more than 1,75 mmol/L was 2,86 (1,03÷7,91). The risk of the development of diabetes mellitus type 2 was significantly increased with age (b=0,11; ехр (b)=1,12 (1,01÷1,23), р<0,03). RR of diabetes mellitus type 2 within patients over the age of 37,74 years was1,52 (1,09÷15,39).The most significant observed risk factors of insulin resistance are the following: class I obesity within men, the thickness of preperitoneal adipose tissue more than 1,50 cm and triglyceride level more than 1,75 mmol/l. When there are no signs of insulin resistance, the age over 37,74 years within men and women.

About the Authors

I. . Savasteeva
ГУ «РНПЦ радиационной медицины и экологии человека»
Russian Federation


V. . Selkina
ГУ «РНПЦ радиационной медицины и экологии человека»
Russian Federation


Y. . Yarets
ГУ «РНПЦ радиационной медицины и экологии человека»
Russian Federation


M. . Rusalenka
ГУ «РНПЦ радиационной медицины и экологии человека»
Russian Federation


References

1. Улучшение показателей по неинфекционным заболеваниям: барьеры и возможности систем здравоохранения / ВОЗ. Руководство по проведению оценки ситуации в странах. Копенгаген. 2016.

2. Рекомендации по диабету, предиабету и сердечно-сосудистым заболеваниям // Российский кардиологический журнал. - 2014. - №3(107). - С. 7-61.

3. International Diabetes Federation. Global Burden: Prevalence and Projections, 2011 and 2030. / 2011. [Электронный ресурс]. 2011. Режим доступа: http://www.diabetesatlas.org/content/diabetes-and-impairedglucose-tolerance.

4. Standarts of Medical Care in Diabetes - 2015 // Diabetes Care. - №38 (1). - Р 25-49.

5. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients / M. Romero-Gomez [et al.] // Gastroenterology. - 2006. - №128 (3). - Р.636-641.

6. Возможности применения нового метаболического индекса при оценке инсулинорезистентности в клинической практике / Г.Е. Ройтберг [и др.] // Рациональная Фармакотерапия в кардиологии. - 2014. - № 10(3). - С 264-274.

7. Алгоритм лучевого исследования висцерального ожирения у больных с метаболическим синдромом / Н.М. Сусляева [и др.] // Бюллетень сибирской медицины. - 2012. - № 5. - С. 27-33.

8. Association of erectile dysfunction and hypogonadism with metabolic syndrome in men with lower urinary tract symptoms of younger and older age groups / E. Novikova [et al.] // Advances in Sexual Medicine. - 2014. - № 4. - P. 55-64.


Review

For citations:


Savasteeva I., Selkina V., Yarets Y., Rusalenka M. Major indicators of insulin resistance in risk assessement of diabetes mellitus development. Medical and Biological Problems of Life Activity. 2022;(1):117-123. (In Russ.)

Views: 101


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2088 (Print)